カテゴリー： Market Monitor Global, 世界, 医療/バイオ

副鼻腔炎治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Sinusitis Medications Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8663 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：62 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Sinusitis Medications Market 調査レポートは次の情報を含め、グローバルにおけるの副鼻腔炎治療薬市場規模と予測を収録しています。・世界の副鼻腔炎治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の副鼻腔炎治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の副鼻腔炎治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗生物質」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

副鼻腔炎治療薬のグローバル主要企業は、Sanofi、 Bayer AG、 Pfizer、 AstraZeneca Plc、 Novartis AG.、 Johnson & Johnson、 Merck、 Amgen、 Bionorica SE、 Dr. Reddy's Laboratories、 Huasunなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、副鼻腔炎治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の副鼻腔炎治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の副鼻腔炎治療薬市場：タイプ別市場シェア、2022年
・抗生物質、コルチコステロイド、鼻詰まり除去剤

世界の副鼻腔炎治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の副鼻腔炎治療薬市場：用途別市場シェア、2022年
・急性副鼻腔炎、慢性副鼻腔炎

世界の副鼻腔炎治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の副鼻腔炎治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における副鼻腔炎治療薬のグローバル売上、2018年-2023年
・主要企業における副鼻腔炎治療薬のグローバル売上シェア、2022年
・主要企業における副鼻腔炎治療薬のグローバル販売量、2018年-2023年
・主要企業における副鼻腔炎治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi、 Bayer AG、 Pfizer、 AstraZeneca Plc、 Novartis AG.、 Johnson & Johnson、 Merck、 Amgen、 Bionorica SE、 Dr. Reddy's Laboratories、 Huasun

*************************************************************

・調査・分析レポートの概要
副鼻腔炎治療薬市場の定義
市場セグメント
世界の副鼻腔炎治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の副鼻腔炎治療薬市場規模
世界の副鼻腔炎治療薬市場規模：2022年 VS 2029年
世界の副鼻腔炎治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの副鼻腔炎治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の副鼻腔炎治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗生物質、コルチコステロイド、鼻詰まり除去剤
副鼻腔炎治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：急性副鼻腔炎、慢性副鼻腔炎
副鼻腔炎治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別副鼻腔炎治療薬市場規模 2022年と2029年
地域別副鼻腔炎治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 Bayer AG、 Pfizer、 AstraZeneca Plc、 Novartis AG.、 Johnson & Johnson、 Merck、 Amgen、 Bionorica SE、 Dr. Reddy's Laboratories、 Huasun
...

Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
This report aims to provide a comprehensive presentation of the global market for Sinusitis Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sinusitis Medications. This report contains market size and forecasts of Sinusitis Medications in global, including the following market information:
Global Sinusitis Medications Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Sinusitis Medications market was valued at US$ 2300.7 million in 2022 and is projected to reach US$ 2878.8 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Drugs For Sinusitis key players include Sanofi, Bayer AG, Pfizer, AstraZeneca Plc, etc. Global top four manufacturers hold a share over 30%.
North America is the largest market, with a share about 35%, followed by Europe, and Asia (Ex.China), both have a share over 40 percent.
In terms of product, Corticosteroids is the largest segment, with a share about 30%. And in terms of application, the largest application is Acute Sinusitis, followed by Acute Sinusitis.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sinusitis Medications companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sinusitis Medications Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Sinusitis Medications Market Segment Percentages, by Type, 2022 (%)
Antibiotics
Corticosteroids
Decongestants
Global Sinusitis Medications Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Sinusitis Medications Market Segment Percentages, by Application, 2022 (%)
Acute Sinusitis
Chronic Sinusitis
Global Sinusitis Medications Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Sinusitis Medications Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sinusitis Medications revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Sinusitis Medications revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Bayer AG
Pfizer
AstraZeneca Plc
Novartis AG.
Johnson & Johnson
Merck
Amgen
Bionorica SE
Dr. Reddy’s Laboratories
Huasun
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sinusitis Medications, market overview.
Chapter 2: Global Sinusitis Medications market size in revenue.
Chapter 3: Detailed analysis of Sinusitis Medications company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sinusitis Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Sinusitis Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sinusitis Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sinusitis Medications Overall Market Size
2.1 Global Sinusitis Medications Market Size: 2022 VS 2029
2.2 Global Sinusitis Medications Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sinusitis Medications Players in Global Market
3.2 Top Global Sinusitis Medications Companies Ranked by Revenue
3.3 Global Sinusitis Medications Revenue by Companies
3.4 Top 3 and Top 5 Sinusitis Medications Companies in Global Market, by Revenue in 2022
3.5 Global Companies Sinusitis Medications Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sinusitis Medications Players in Global Market
3.6.1 List of Global Tier 1 Sinusitis Medications Companies
3.6.2 List of Global Tier 2 and Tier 3 Sinusitis Medications Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Sinusitis Medications Market Size Markets, 2022 & 2029
4.1.2 Antibiotics
4.1.3 Corticosteroids
4.1.4 Decongestants
4.2 By Type – Global Sinusitis Medications Revenue & Forecasts
4.2.1 By Type – Global Sinusitis Medications Revenue, 2018-2023
4.2.2 By Type – Global Sinusitis Medications Revenue, 2024-2029
4.2.3 By Type – Global Sinusitis Medications Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Sinusitis Medications Market Size, 2022 & 2029
5.1.2 Acute Sinusitis
5.1.3 Chronic Sinusitis
5.2 By Application – Global Sinusitis Medications Revenue & Forecasts
5.2.1 By Application – Global Sinusitis Medications Revenue, 2018-2023
5.2.2 By Application – Global Sinusitis Medications Revenue, 2024-2029
5.2.3 By Application – Global Sinusitis Medications Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Sinusitis Medications Market Size, 2022 & 2029
6.2 By Region – Global Sinusitis Medications Revenue & Forecasts
6.2.1 By Region – Global Sinusitis Medications Revenue, 2018-2023
6.2.2 By Region – Global Sinusitis Medications Revenue, 2024-2029
6.2.3 By Region – Global Sinusitis Medications Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Sinusitis Medications Revenue, 2018-2029
6.3.2 US Sinusitis Medications Market Size, 2018-2029
6.3.3 Canada Sinusitis Medications Market Size, 2018-2029
6.3.4 Mexico Sinusitis Medications Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Sinusitis Medications Revenue, 2018-2029
6.4.2 Germany Sinusitis Medications Market Size, 2018-2029
6.4.3 France Sinusitis Medications Market Size, 2018-2029
6.4.4 U.K. Sinusitis Medications Market Size, 2018-2029
6.4.5 Italy Sinusitis Medications Market Size, 2018-2029
6.4.6 Russia Sinusitis Medications Market Size, 2018-2029
6.4.7 Nordic Countries Sinusitis Medications Market Size, 2018-2029
6.4.8 Benelux Sinusitis Medications Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Sinusitis Medications Revenue, 2018-2029
6.5.2 China Sinusitis Medications Market Size, 2018-2029
6.5.3 Japan Sinusitis Medications Market Size, 2018-2029
6.5.4 South Korea Sinusitis Medications Market Size, 2018-2029
6.5.5 Southeast Asia Sinusitis Medications Market Size, 2018-2029
6.5.6 India Sinusitis Medications Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Sinusitis Medications Revenue, 2018-2029
6.6.2 Brazil Sinusitis Medications Market Size, 2018-2029
6.6.3 Argentina Sinusitis Medications Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Sinusitis Medications Revenue, 2018-2029
6.7.2 Turkey Sinusitis Medications Market Size, 2018-2029
6.7.3 Israel Sinusitis Medications Market Size, 2018-2029
6.7.4 Saudi Arabia Sinusitis Medications Market Size, 2018-2029
6.7.5 UAE Sinusitis Medications Market Size, 2018-2029
7 Sinusitis Medications Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Sinusitis Medications Major Product Offerings
7.1.4 Sanofi Sinusitis Medications Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Bayer AG
7.2.1 Bayer AG Company Summary
7.2.2 Bayer AG Business Overview
7.2.3 Bayer AG Sinusitis Medications Major Product Offerings
7.2.4 Bayer AG Sinusitis Medications Revenue in Global Market (2018-2023)
7.2.5 Bayer AG Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Sinusitis Medications Major Product Offerings
7.3.4 Pfizer Sinusitis Medications Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 AstraZeneca Plc
7.4.1 AstraZeneca Plc Company Summary
7.4.2 AstraZeneca Plc Business Overview
7.4.3 AstraZeneca Plc Sinusitis Medications Major Product Offerings
7.4.4 AstraZeneca Plc Sinusitis Medications Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca Plc Key News & Latest Developments
7.5 Novartis AG.
7.5.1 Novartis AG. Company Summary
7.5.2 Novartis AG. Business Overview
7.5.3 Novartis AG. Sinusitis Medications Major Product Offerings
7.5.4 Novartis AG. Sinusitis Medications Revenue in Global Market (2018-2023)
7.5.5 Novartis AG. Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Sinusitis Medications Major Product Offerings
7.6.4 Johnson & Johnson Sinusitis Medications Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Sinusitis Medications Major Product Offerings
7.7.4 Merck Sinusitis Medications Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Sinusitis Medications Major Product Offerings
7.8.4 Amgen Sinusitis Medications Revenue in Global Market (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 Bionorica SE
7.9.1 Bionorica SE Company Summary
7.9.2 Bionorica SE Business Overview
7.9.3 Bionorica SE Sinusitis Medications Major Product Offerings
7.9.4 Bionorica SE Sinusitis Medications Revenue in Global Market (2018-2023)
7.9.5 Bionorica SE Key News & Latest Developments
7.10 Dr. Reddy’s Laboratories
7.10.1 Dr. Reddy’s Laboratories Company Summary
7.10.2 Dr. Reddy’s Laboratories Business Overview
7.10.3 Dr. Reddy’s Laboratories Sinusitis Medications Major Product Offerings
7.10.4 Dr. Reddy’s Laboratories Sinusitis Medications Revenue in Global Market (2018-2023)
7.10.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.11 Huasun
7.11.1 Huasun Company Summary
7.11.2 Huasun Business Overview
7.11.3 Huasun Sinusitis Medications Major Product Offerings
7.11.4 Huasun Sinusitis Medications Revenue in Global Market (2018-2023)
7.11.5 Huasun Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Sinusitis Medications Market Opportunities & Trends in Global Market
Table 2. Sinusitis Medications Market Drivers in Global Market
Table 3. Sinusitis Medications Market Restraints in Global Market
Table 4. Key Players of Sinusitis Medications in Global Market
Table 5. Top Sinusitis Medications Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Sinusitis Medications Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Sinusitis Medications Revenue Share by Companies, 2018-2023
Table 8. Global Companies Sinusitis Medications Product Type
Table 9. List of Global Tier 1 Sinusitis Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sinusitis Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Sinusitis Medications Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Sinusitis Medications Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Sinusitis Medications Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Sinusitis Medications Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Sinusitis Medications Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Sinusitis Medications Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Sinusitis Medications Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Sinusitis Medications Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Sinusitis Medications Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Sinusitis Medications Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Sinusitis Medications Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Sinusitis Medications Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Sinusitis Medications Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Sinusitis Medications Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Sinusitis Medications Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Sinusitis Medications Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Sinusitis Medications Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Sinusitis Medications Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Sinusitis Medications Revenue, (US$, Mn), 2024-2029
Table 30. Sanofi Company Summary
Table 31. Sanofi Sinusitis Medications Product Offerings
Table 32. Sanofi Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Bayer AG Company Summary
Table 35. Bayer AG Sinusitis Medications Product Offerings
Table 36. Bayer AG Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer AG Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Sinusitis Medications Product Offerings
Table 40. Pfizer Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. AstraZeneca Plc Company Summary
Table 43. AstraZeneca Plc Sinusitis Medications Product Offerings
Table 44. AstraZeneca Plc Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca Plc Key News & Latest Developments
Table 46. Novartis AG. Company Summary
Table 47. Novartis AG. Sinusitis Medications Product Offerings
Table 48. Novartis AG. Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis AG. Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Sinusitis Medications Product Offerings
Table 52. Johnson & Johnson Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Sinusitis Medications Product Offerings
Table 56. Merck Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Sinusitis Medications Product Offerings
Table 60. Amgen Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. Bionorica SE Company Summary
Table 63. Bionorica SE Sinusitis Medications Product Offerings
Table 64. Bionorica SE Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 65. Bionorica SE Key News & Latest Developments
Table 66. Dr. Reddy's Laboratories Company Summary
Table 67. Dr. Reddy's Laboratories Sinusitis Medications Product Offerings
Table 68. Dr. Reddy's Laboratories Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 69. Dr. Reddy's Laboratories Key News & Latest Developments
Table 70. Huasun Company Summary
Table 71. Huasun Sinusitis Medications Product Offerings
Table 72. Huasun Sinusitis Medications Revenue (US$, Mn) & (2018-2023)
Table 73. Huasun Key News & Latest Developments
List of Figures
Figure 1. Sinusitis Medications Segment by Type in 2022
Figure 2. Sinusitis Medications Segment by Application in 2022
Figure 3. Global Sinusitis Medications Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sinusitis Medications Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Sinusitis Medications Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sinusitis Medications Revenue in 2022
Figure 8. By Type - Global Sinusitis Medications Revenue Market Share, 2018-2029
Figure 9. By Application - Global Sinusitis Medications Revenue Market Share, 2018-2029
Figure 10. By Type - Global Sinusitis Medications Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Sinusitis Medications Revenue Market Share, 2018-2029
Figure 12. By Application - Global Sinusitis Medications Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Sinusitis Medications Revenue Market Share, 2018-2029
Figure 14. By Region - Global Sinusitis Medications Revenue Market Share, 2018-2029
Figure 15. By Country - North America Sinusitis Medications Revenue Market Share, 2018-2029
Figure 16. US Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Sinusitis Medications Revenue Market Share, 2018-2029
Figure 20. Germany Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 21. France Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Sinusitis Medications Revenue Market Share, 2018-2029
Figure 28. China Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 32. India Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Sinusitis Medications Revenue Market Share, 2018-2029
Figure 34. Brazil Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Sinusitis Medications Revenue Market Share, 2018-2029
Figure 37. Turkey Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Sinusitis Medications Revenue, (US$, Mn), 2018-2029
Figure 41. Sanofi Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer AG Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca Plc Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis AG. Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Amgen Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bionorica SE Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Dr. Reddy's Laboratories Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Huasun Sinusitis Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 副鼻腔炎治療薬の世界市場見通し2023年-2029年(Sinusitis Medications Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

副鼻腔炎治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp